D&D Pharmatech

D&D Pharmatech

Develops and researches alzheimer disease, parkinson, and other drugs. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$204—306m (Dealroom.co estimates Oct 2021.)
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...